NOVO-MEPRO 400MG DIN 00021547
Health Canada record
| Active ingredient(s) | MEPROBAMATE 400 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | TARGETED SUBSTANCES (CDSA IV) |
| Class | Human |
| ATC | N05BC01 MEPROBAMATE |
| Original market date | 31-Dec-1967 |
| Current status date | 10-Aug-2005 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MEPROBAMATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00337943 | APO MEPROBAMATE TAB 400MG | APOTEX INC | Tablet | MEPROBAMATE 400 MG | Cancelled Post Market |
| 02041804 | EQUAGESIC TABLETS | WYETH-AYERST CANADA INC. | Tablet | MEPROBAMATE 200 MG; ETHOHEPTAZINE CITRATE 75 MG; ACETYLSALICYLIC ACID 250 MG | Cancelled Post Market |
| 02041812 | EQUANIL TABLETS 400MG | WYETH-AYERST CANADA INC. | Tablet | MEPROBAMATE 400 MG | Cancelled Post Market |
| 00134368 | MEDITRAN 400MG | MEDIC LABORATORY LTÉE | Tablet | MEPROBAMATE 400 MG | Cancelled Post Market |
| 00156620 | MEPROBAMATE TAB 400MG | PRO DOC LIMITEE | Tablet | MEPROBAMATE 400 MG | Cancelled Post Market |
| 00431095 | MEPROBAMATE TAB 400MG | DUCHESNAY INC | Tablet | MEPROBAMATE 400 MG | Cancelled Post Market |
| 00021539 | NOVO-MEPRO 200MG | NOVOPHARM LIMITED | Tablet | MEPROBAMATE 200 MG | Cancelled Post Market |
International API supply for MEPROBAMATE
7 active FDA Drug Master Files.
Request a quote for NOVO-MEPRO 400MG